Nerve function and dysfunction in acute intermittent porphyria

Brain

Volumn 131, Issue 9, 2008, Pages 2510-2519

  Lin, Cindy S Y ^a,b   Krishnan, Arun V ^a,b   Lee, Ming Jen ^c   Zagami, Alessandro S ^a   You, Hui Ling ^c   Yang, Chih Chao ^c   Bostock, Hugh ^d   Kiernan, Matthew C ^a,b,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Haem; Inward rectification (IH); Ischaemia; Nerve excitability; Porphyria

Indexed keywords

CYCLIC NUCLEOTIDE; PORPHOBILINOGEN DEAMINASE; PORPHYRIN DERIVATIVE;

ACUTE INTERMITTENT PORPHYRIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; HYPERPOLARIZATION; MALE; MATHEMATICAL MODEL; MEMBRANE DEPOLARIZATION; NERVE CONDUCTION; NERVE EXCITABILITY; NERVE FIBER MEMBRANE; NERVE FUNCTION; NEUROPATHY; NEUROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPRODUCIBILITY; SCHOOL CHILD; STIMULUS RESPONSE;

EID: 50849096052     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn152     Document Type: Article

References (55)

1. Albers JW, Fink JK. Porphyric neuropathy. Muscle Nerve 2004; 30: 410-22.
2. Arnold WN. The illness of Vincent van Gogh. J Hist Neurosci 2004; 13: 22-43.
3. Baker M, Bostock H, Grafe P, Martius P. Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J Physiol 1987; 383: 45-67.
4. Barrett EF, Barrett JN. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol 1982; 323: 117-44.
5. Becker DM, Goldstuck N, Kramer S. Effect of delta-aminolaevulinic acid on the resting membrane potential of frog sartorius muscle. S Afr Med J 1975; 49: 1790-2.
6. Becker D, Viljoen D, Kramer S. The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid. Biochim Biophys Acta 1971; 225: 26-34.
7. Blight AR. Computer simulation of action potentials and afterpotentials in mammalian myelinated axons: the case for a lower resistance myelin sheath. Neuroscience 1985; 15: 13-31.
8. Bostock H, Baker M. Evidence for two types of potassium channel in human motor axons in vivo. Brain Res 1988; 462: 354-8.
9. Bostock H, Baker M, Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol 1991; 441: 537-57.
10. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998; 21: 137-58.
11. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 1997; 498: 277-94.
12. Bostock H, Sharief MK, Reid G, Murray NMF. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995; 118: 217-25.
13. Bowe CM, Kocsis JD, Waxman SG. The association of the supernormal period and the depolarizing afterpotential in myelinated frog and rat sciatic nerve. Neuroscience 1987; 21: 585-93.
14. Burke D, Skuse NF, Lethlean AK. Sensory conduction of the sural nerve in polyneuropathy. J Neurol Neurosurg Psychiatry 1974; 37: 647-52.
15. Cox TM, Jack N, Lofthouse S, Watling J, Haines J, Warren MJ. King George III and porphyria: an elemental hypothesis and investigation. Lancet 2005; 366: 332-5.
16. DeFrancisco M, Savino PJ, Schatz NJ. Optic atrophy in acute intermittent porphyria. Am J Ophthalmol 1979; 87: 221-4.
17. Duchen MR. Effects of metabolic inhibition on the membrane properties of isolated mouse primary sensory neurones. J Physiol 1990; 424: 387-409.
18. Eduardo E, Burke D. The optimal recording electrode configuration for compound sensory action potentials. J Neurol Neurosurg Psychiatry 1988; 51: 684-7.
19. Herrick AL, McColl KEL. Acute intermittent porphyria. Best Pract Res Clin Gastroenterol 2005; 19: 235-49.
20. Herrick AL, McColl KE, McLellan A, Moore MR, Brodie MJ, Goldberg A. Effect of haem arginate therapy on porphyrin metabolism and mixed function oxygenase activity in acute hepatic porphyria. Lancet 1987; 21: 1178-9.
21. Horn S, Quasthoff S, Grafe P, Bostock H, Renner R, Schrank B. Abnormal axonal inward rectification in diabetic neuropathy. Muscle Nerve 1996; 19: 1268-75.
22. Hrdinka M, Puy H, Martasek P. May 2006 update in porphobilinogen deaminase gene polymorphisims and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population. Physiol Res 2006; 55: S119-36.
23. Jankelowitz SK, Howells J, Burke D. Plasticity of inwardly rectifying conductances following a corticospinal lesion in human subjects. J Physiol 2007; 581: 927-40.
24. Kaji R. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve 2003; 27: 285-96.
25. Kaji R, Sumner AJ. Ouabain reverses conduction disturbances in single demyelinated nerve fibers. Neurology 1989; 39: 1364-8.
26. Kauppinen R. Porphyrias. Lancet 2005; 365: 241-52.
27. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000; 123: 2542-51.
28. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000; 23: 399-409.
29. Kiernan MC, Burke D, Bostock H. Nerve excitability measures: biophysical basis and use in the investigation of peripheral nerve disease. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsevier Saunders; 2005a. p. 113-30.
30. Kiernan MC, Cikurel K, Bostock H. Effects of temperature on the excitability properties of human motor axons. Brain 2001a; 124: 816-25.
31. Kiernan MC, Isbister GK, Lin CS, Burke D, Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005b; 57: 339-48.
32. Kiernan MC, Krishnan AV, Lin CSY, Burke D, Berkovic SF. Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability. Brain 2005c; 128: 1841-6.
33. Kiernan MC, Lin CS, Andersen KV, Murray NM, Bostock H. Clinical evaluation of excitability measures in sensory nerve. Muscle Nerve. 2001b; 24: 883-92.
34. Kimura J. Electrodiagnosis in diseases of nerve and muscle. Philadelphia: FA Davis; 1983.
35. Kitano Y, Kuwabara S, Misawa S, Ogawara K, Kanai K, Kikkawa Y, et al. The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol 2004; 56: 462-7.
36. Kordac V, Kozáková M, Martásek P. Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration. Ann Med 1989; 21: 273-6.
37. Krishnan AV, Kiernan MC. Altered nerve excitability properties in established diabetic neuropathy. Brain 2005; 128: 1178-87.
38. Krishnan AV, Lin CS-Y, Kiernan MC. Nerve excitability properties in lower limb motor axons: evidence for a length-dependent gradient. Muscle Nerve 2004; 29: 645-55.
39. Krishnan AV, Lin CS-Y, Kiernan MC. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy. Brain 2008; 131: 1209-16.
40. Kuwabara S, Ogawara K, Sung JY, Mori M, Kanai K, Hattori T, et al. Differences in membrane properties of axonal and demyelinating Guillain-Barre syndromes. Ann Neurol 2002; 52: 180-7.
41. Lithner F. Could attacks of abdominal pain in cases of acute intermittent porphyria be due to intestinal angina? J Intern Med 2000; 247: 407-9.
42. Ma DM, Liveson JA. Nerve conduction handbook. Philadelphia: FA Davis; 1983.
43. McCormick DA, Pape HC. Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neurones. J Physiol 1990; 431: 291-318.
44. Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 1998; 18: 43-52.
45. Munsch T, Pape H-C. Modulation of the hyperpolarization-activated cation current of rat thalamic relay neurones by intracellular pH. J Physiol 1999; 519: 493-504.
46. Pape HC. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Annu Rev Physiol 1996; 58: 299-327.
47. Peters TJ, Deacon AC. International air travel: a risk factor for attacks in acute intermittent porphyria. Clin Chim Acta 2003; 335: 59-63.
48. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical recipes in C - The art of computing. Cambridge: Cambridge University Press; 1992.
49. Quasthoff S. The role of axonal ion conductances in diabetic neuropathy: a review. Muscle Nerve 1998; 21: 1246-55.
50. Schwarz JR, Glassmeier G, Cooper EC, Kao TC, Nodera H, Tabuena D, et al. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier. J Physiol (Lond) 2006; 573: 17-34.
51. Schwarz JR, Reid G, Bostock H. Action potentials and membrane currents in the human node of Ranvier. Pflugers Arch Eur J Physiol 1995; 430: 283-92.
52. Stys PK, Waxman SG. Activity-dependent modulation of excitability: implications for axonal physiology and pathophysiology. Muscle Nerve 1994; 17: 969-74.
53. Tokimasa T, Akasu T. Cyclic AMP regulates an inward rectifying sodium-potassium current in dissociated bull-frog sympathetic neurones. J Physiol 1990; 420: 409-29.
54. Yang Q, Kaji R, Takagi T, Kohara N, Murase N, Yamada Y, et al. Abnormal axonal inward rectifier in streptozocin-induced experimental diabetic neuropathy. Brain 2001; 124: 1149-55.
55. Z'Graggen WJ, Lin CSY, Howard RS, Beale RJ, Bostock H. Nerve excitability changes in critical illness polyneuropathy. Brain 2006; 129: 2461-70.